2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Buy
63
AMRX Quote, Financials, Valuation and Earnings
Last price:
$8.63
Seasonality move
:
13.22%
Day range:
$8.72 - $8.95
52-week range:
$5.18 - $9.48
Dividend yield:
0%
P/E ratio:
101.17x
P/S ratio:
0.98x
P/B ratio:
5.62x
Volume:
4.7M
Avg. volume:
1.7M
1-year change:
62.34%
Market cap:
$2.7B
Revenue:
$2.8B
EPS (TTM):
-$0.38
Earnings Data
Next earnings date for AMRX
May 02
2025
Most recent earnings per share
-$0.10
Missed by $0.25
(Feb 28/2025)
Consensus Estimate
$0.15
(Feb 28/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AMRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/02/2025 | Q1 | $723.1M | -- | -- | $0.17 | -- |
| 02/28/2025 | Q4 | $708.1M | $730.5M | -$0.10 | $0.15 | -$0.25 |
| 11/08/2024 | Q3 | $693.7M | $702.5M | -$0.00 | $0.14 | -$0.14 |
| 08/09/2024 | Q2 | $657.5M | $701.8M | $0.02 | $0.14 | -$0.12 |
| 05/03/2024 | Q1 | $619M | $659.2M | -$0.30 | $0.09 | -$0.39 |
| 03/01/2024 | Q4 | $634.9M | $617M | -$0.40 | $0.09 | -$0.49 |
| 11/07/2023 | Q3 | -- | -- | $0.06 | $0.13 | -$0.07 |
| 08/04/2023 | Q2 | -- | -- | $0.08 | $0.10 | -$0.02 |
| 05/05/2023 | Q1 | -- | -- | -$0.05 | $0.10 | -$0.15 |
| 03/02/2023 | Q4 | -- | -- | -$0.03 | $0.21 | -$0.24 |
| 11/04/2022 | Q3 | -- | -- | -$0.02 | $0.18 | -$0.20 |
| 08/05/2022 | Q2 | -- | -- | -$0.80 | $0.19 | -$0.99 |
| 05/04/2022 | Q1 | -- | -- | -$0.01 | $0.13 | -$0.14 |
| 03/02/2022 | Q4 | -- | -- | -$0.04 | $0.20 | -$0.24 |
| 11/03/2021 | Q3 | -- | -- | -$0.03 | $0.20 | -$0.23 |
| 08/09/2021 | Q2 | -- | -- | $0.10 | $0.18 | -$0.08 |
| 05/07/2021 | Q1 | -- | -- | $0.04 | $0.18 | -$0.14 |
| 02/26/2021 | Q4 | -- | -- | -$0.02 | $0.13 | -$0.15 |
| 11/06/2020 | Q3 | -- | -- | -$0.06 | $0.12 | -$0.18 |
| 08/06/2020 | Q2 | -- | -- | -$0.08 | $0.10 | -$0.18 |
| 05/11/2020 | Q1 | -- | -- | $0.78 | $0.09 | $0.69 |
| 02/26/2020 | Q4 | -- | -- | -$0.23 | $0.05 | -$0.28 |
| 11/06/2019 | Q3 | -- | -- | -$2.03 | $0.13 | -$2.16 |
| 08/08/2019 | Q2 | -- | -- | $0.09 | $0.12 | -$0.03 |
| 05/09/2019 | Q1 | -- | -- | $0.14 | $0.18 | -$0.04 |
| 02/28/2019 | Q4 | -- | -- | $0.33 | $0.27 | $0.06 |
| 11/07/2018 | Q3 | -- | -- | $0.28 | $0.27 | $0.01 |
| 08/09/2018 | Q2 | -- | -- | $0.24 | $0.22 | $0.02 |
| 03/31/2018 | Q1 | -- | -- | $0.14 | -- | -- |
Amneal Pharmaceuticals Earnings Questions
-
How Much did Amneal Pharmaceuticals Generate in Revenue Last Quarter?
Amneal Pharmaceuticals reported $730.5M worth of top line sales in its most recent quarter.
-
Did Amneal Pharmaceuticals Beat Earnings Last Quarter?
Amneal Pharmaceuticals announced earnings per share of -$0.10 which represents a miss of analyst forecast a $0.15 per share.
-
Is Amneal Pharmaceuticals Profitable?
Amneal Pharmaceuticals reported $262.9M that represents $0.85 per share over the last quarter.
-
What is the Analyst Consensus for Amneal Pharmaceuticals EPS Next Year?
Amneal Pharmaceuticals's earnings are forecast to grow from -$0.38 per share to $0.61 per share next year representing an increase of --.
-
When is Amneal Pharmaceuticals's Earnings Date?
Amneal Pharmaceuticals's next earnings date is May 2, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Is Goldman Sachs Stock a Buy Sell or Hold?
When the Federal Reserve started hiking rates in 2022, banks’…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 0.49% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.8% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 4.82% over the past day.
